Adaptive Intervention Model for Hypertension Self-Management in Rural Areas: A Doctor-Patient Interaction Approach
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorYuju Wu
About this trial
The aim of this project is to develop and validate an adaptive intervention model to improve self-management behavior in rural hypertensive patients. The primary question it seeks to answer is: Can a tailored, interaction-based intervention model, guided by key doctor-patient interaction elements, effectively enhance self-management behavior among rural hypertensive patients and improve long-term blood pressure control? Researchers will evaluate the impact of different intervention strategies on self-management behavior and identify the most effective combination to establish a sustainable intervention model for rural hypertension management.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosed hypertension patients who are permanent residents in rural areas.
No plans for long-term relocation within the next year.
Willing to participate in this study.
No cognitive impairment.
Disqualifiers
Age over 80 years.
Having conditions such as stroke, paralysis, or mental disorders that prevent the completion of self-management behaviors.
Severe hearing impairment or speech disorders that prevent participation in interviews.
Likely to relocate or be away from the local area for an extended period within one year.
Trial design
Design model
Sequential
Treatments tested in this trial
Standard Interactive Intervention for Hypertension Management
BehavioralThe standard interactive intervention is a doctor-patient interaction intervention conducted by follow-up physicians using an intelligent outbound call system as part of follow-up management. It is implemented once a month and is designed based on the Health Behavior Interaction Model, covering four key aspects: health information (e.g., potential risks of poor self-management behavior), professional skills(e.g., blood pressure measurement, medication guidance), emotional support , and decision-making participation.
Intensified Interactive Intervention for Hypertension Management
BehavioralThe enhanced interactive intervention builds upon the standard interactive intervention by increasing the frequency of interactions. In addition to the monthly intervention, patients receive an additional brief interactive intervention every two weeks via the intelligent outbound call system, reminding them to adhere to self-management behaviors for hypertension control.
Treatment groups
320 Participants
are divided into 6 treatment groups6
Treatment groupsSee each treatment group below.
Group A: Standard Interactive Intervention with Continued Standard Intervention for Poor Self-ManagementExperimental treatment 1 intervention
Group B: Standard Interactive Intervention Followed by Enhanced Intervention for Poor Self-ManagementExperimental treatment 1 intervention
Group C: Standard Interactive Intervention Followed by Regular Follow-Up ManagementExperimental treatment 1 intervention
Group D: Intensified Interactive Intervention Followed by Standard Interactive InterventionExperimental treatment 1 intervention
Group E: Intensified Interactive Intervention Followed by Routine Follow-UpExperimental treatment 1 intervention
Group F: Intensified Interactive Intervention with Continued IntensificationExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Hypertension self-management behavior
Hypertension self-management behavior includes six dimensions: medication management, condition monitoring, dietary management, exercise management, work and rest management, and emotional management. Each item is scored on a 1 to 5 scale, with a total score ranging from 33 to 165. A higher total score indicates a higher level of self-management in patients.
Time frame
From the start of the intervention to the 6-month and the end of the trial at 12 months.2
Blood pressure
Time frame
From the start of the intervention to the 6-month and the end of the trial at 12 months.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Yuju Wu
Lead sponsor
Sichuan University
Sponsor institution
Source ClinicalTrials.gov